 | • レポートコード：QFJ1-4288 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、医療関連感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿路感染症、手術部位感染症、院内肺炎、菌血症、胃腸感染症）、用途別市場規模（病院、診療所、ASC）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・医療関連感染症診断の市場動向 ・企業の競争状況、市場シェア ・医療関連感染症診断の種類別市場規模と予測2016-2027（尿路感染症、手術部位感染症、院内肺炎、菌血症、胃腸感染症） ・医療関連感染症診断の用途別市場規模と予測2016-2027（病院、診療所、ASC） ・医療関連感染症診断の北米市場規模2016-2027（アメリカ、カナダ） ・医療関連感染症診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・医療関連感染症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・医療関連感染症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・医療関連感染症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Accelerate Diagnostics、BD、bioMrieux、Bio-Rad、DiaSorin Molecular、F. Hoffmann-La Roche、Luminex、Meridian Bioscience、OpGen、QIAGEN、Quidel、Thermo Fisher Scientific、Trinity Biotech、Danaher） ・結論 |
Diagnosis of health care-associated infectious diseases.
Diagnosis of health care-associated infectious diseases.
Market Analysis and Insights: Global Healthcare-associated Infectious Disease Diagnostics Market
The global Healthcare-associated Infectious Disease Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Healthcare-associated Infectious Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Healthcare-associated Infectious Disease Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Healthcare-associated Infectious Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Healthcare-associated Infectious Disease Diagnostics market.
Global Healthcare-associated Infectious Disease Diagnostics Scope and Market Size
Healthcare-associated Infectious Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare-associated Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Urinary Tract Infections
Surgical Site Infections
Hospital-acquired Pneumonia
BloodStream Infections
Gastrointestinal Infections
Segment by Application
Hospitals
Clinics
ASCs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Accelerate Diagnostics
BD
bioMrieux
Bio-Rad
DiaSorin Molecular
F. Hoffmann-La Roche
Luminex
Meridian Bioscience
OpGen
QIAGEN
Quidel
Thermo Fisher Scientific
Trinity Biotech
Danaher
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urinary Tract Infections
1.2.3 Surgical Site Infections
1.2.4 Hospital-acquired Pneumonia
1.2.5 BloodStream Infections
1.2.6 Gastrointestinal Infections
1.3 Market by Application
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2016-2027)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.2.5 Accelerate Diagnostics Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.3.5 BD Recent Development
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.4.5 bioMrieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.5.5 Bio-Rad Recent Development
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Details
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.6.5 DiaSorin Molecular Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.8.5 Luminex Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.9.5 Meridian Bioscience Recent Development
11.10 OpGen
11.10.1 OpGen Company Details
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.10.5 OpGen Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Details
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.11.5 QIAGEN Recent Development
11.12 Quidel
11.12.1 Quidel Company Details
11.12.2 Quidel Business Overview
11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.12.5 Quidel Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Details
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.14.5 Trinity Biotech Recent Development
11.15 Danaher
11.15.1 Danaher Company Details
11.15.2 Danaher Business Overview
11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.15.5 Danaher Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2016-2021)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Accelerate Diagnostics Company Details
Table 70. Accelerate Diagnostics Business Overview
Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Accelerate Diagnostics Recent Development
Table 74. BD Company Details
Table 75. BD Business Overview
Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 78. BD Recent Development
Table 79. bioMrieux Company Details
Table 80. bioMrieux Business Overview
Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 83. bioMrieux Recent Development
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Bio-Rad Recent Development
Table 89. DiaSorin Molecular Company Details
Table 90. DiaSorin Molecular Business Overview
Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 93. DiaSorin Molecular Recent Development
Table 94. F. Hoffmann-La Roche Company Details
Table 95. F. Hoffmann-La Roche Business Overview
Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 98. F. Hoffmann-La Roche Recent Development
Table 99. Luminex Company Details
Table 100. Luminex Business Overview
Table 101. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Luminex Recent Development
Table 103. Meridian Bioscience Company Details
Table 104. Meridian Bioscience Business Overview
Table 105. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 106. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 107. Meridian Bioscience Recent Development
Table 108. OpGen Company Details
Table 109. OpGen Business Overview
Table 110. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 111. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 112. OpGen Recent Development
Table 113. QIAGEN Company Details
Table 114. QIAGEN Business Overview
Table 115. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 116. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 117. QIAGEN Recent Development
Table 118. Quidel Company Details
Table 119. Quidel Business Overview
Table 120. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 121. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Quidel Recent Development
Table 123. Thermo Fisher Scientific Company Details
Table 124. Thermo Fisher Scientific Business Overview
Table 125. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 126. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 127. Thermo Fisher Scientific Recent Development
Table 128. Trinity Biotech Company Details
Table 129. Trinity Biotech Business Overview
Table 130. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 131. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 132. Trinity Biotech Recent Development
Table 133. Danaher Company Details
Table 134. Danaher Business Overview
Table 135. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 136. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 137. Danaher Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Urinary Tract Infections Features
Figure 3. Surgical Site Infections Features
Figure 4. Hospital-acquired Pneumonia Features
Figure 5. BloodStream Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2020
Figure 17. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2016-2027)
Figure 41. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 49. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 50. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 51. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 57. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 61. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 62. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 63. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 64. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 65. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 67. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 68. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 69. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 70. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 71. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 72. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 73. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 74. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の院内感染治療市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…- 世界の後天性感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Infections Testing Market The global Acquired Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のポイントオブケア感染症市場規模・現状・予測（2021年-2027年） A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management. Market Analysis and Insights: Global Point…
- 世界の院内感染 (HAI) 診断市場規模・現状・予測（2021年-2027年） A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infectio…
- 世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…